Microbial Biofilms: Pathogenicity and Treatment strategies

January 2018 ARTICLE LIST >>

PharmaTutor (January - 2018)

ISSN: 2347 - 7881
(Volume 6, Issue 1)

Received On: 13/10/2017; Accepted On: 28/11/2017; Published On: 01/01/2018

AUTHORS:
Smrutipragnya Samal, Pratyush Kumar Das*
Centre for Biotechnology,
Siksha ‘O’ Anusandhan University,
Bhubaneswar, Odisha, India.
*pratyushdas@soauniversity.ac.in

ABSTRACT:
Microbial biofilms are complex structures wherein the planktonic cells change their growth mode to the sessile form. This kind of growth is assisted by the formation of a matrix of extracellular polymeric substances (EPS) which encapsulates the bacterial cells within it and thus, provides an additional protection. These biofilms are highly resistant to high concentration of antibiotics and poses a great threat towards public health. These biofilms are even beyond the access of a normal human immune system and are involved in infections of teeth, lungs and many other diseases. There lies an immediate need to replace the extensive use of antibiotics with new emerging strategies. The review intends to provide an insight on the various perspectives of microbial biofilms including their formation, composition, mechanism of communication (Quorum sensing) and pathogenicity. Recent emerging strategies have also been discussed that can be considered for successful eradication or inhibition of biofilms and related infections.

How to cite this article: Samal S, Das PK; Microbial Biofilms: Pathogenicity and Treatment strategies; PharmaTutor; 2018; 6(1); 16-22; https://dx.doi.org/10.29161/PT.v6.i1.2018.16

[ABSTRACT WITH CITATION] [VIEW AS HTML]

REFERENCES:
1. Baselga R. et al., “Staphylococcus aureus capsule and slime as virulence factors in ruminant mastitis. A review”. Vet Microbiol., 1994; 39; 195-204.
2. Bayer A.S., Speert D.P., Park S., Tu J., Witt M., Nast C.C., Norman D.C., “Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte mediated killing of Pseudomonas aeruginosa”. Infect. Immun., 1991; 59; 302–308.
3. Bjarnsholt T., Kirketerp-Møller K., Kristiansen S., Phipps R., Nielsen A.K., Jensen PØ, Høiby N., Givskov M., “Silver against Pseudomonas aeruginosa biofilms”. APMIS. 2007; 115; 921-928.
4. Cochrane D.M.G., “Immune response to bacterial biofilms”. Med Microbiol J., 1988; 27; 255.
5. Costerton J., Stewart P.S., Greenberg E.B., “Bacterial biofilms: a common cause of persistent infections”. Sci., 1999; 284; 1318-1322.
6. Caubet R., Pedarros-Caubet F., Chu M., Freye E., de Belém Rodrigues M., Moreau J.M., Ellison W.J., “A radio frequency electric current enhances antibiotic efficacy against bacterial biofilms”. Antimicrobial Agents Chemother., 2004; 48; 4662-4664. DOI: 10.1128/AAC.48.12.4662-4664.2004
7. De Kievit T.R., Parkins M.D., Gillis R.J., Srikumar R., Ceri H., Poole K., Iglewski B.H., Storey D.G., “Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms”. Antimicrobial agents and Chemother., 2001; 45; 1761-1770. DOI: 10.1128/AAC.45.6.1761-1770.2001
8. Donlan R.M., Costerton J.W., “Biofilms: survival mechanisms of clinically relevant microorganisms”. Clin Microbiol Rev., 2002; 15; 167-193.
9. Durack D.T., Beeson P.B., “Experimental bacterial endocarditis. II. Survival of bacteria in endocardial vegetations”. Br J Exp Pathol., 1972; 53; 50-53.
10. Fux C.A., Costerton J.W., Stewart P.S., Stoodley P., “Survival strategies of infectious biofilms”. Trends Microbiol., 2005; 13; 34-40.
11. Gavin L., Gillian D.L., “Microbial Biofilms: Current Research and Applications”. New Zealand. Caister Academic Press. 2012. ISBN: 978-1-904455-96-7
12. Gilbert P. et al., “Biofilm susceptibility to antimicrobials”. Advn Dental Res., 1997; 11; 160-167.
13. Habash M.B., van der Mei H.C., Busscher H.J., Reid G., “The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber”. Can. J. Microbiol., 1999; 45; 691–694.
14. Hall-Stoodley L., Costerton J.W., Stoodley, P., “Bacterial biofilms: from the natural environment to infectious diseases”. Nat Rev Microbiol., 2004; 2; 95-108.
15. Hall-Stoodley L., Hu F.Z., Gieseke A., Nistico L., Nguyen D., Hayes J. et al., “Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media”. JAMA. 2006; 296(2); 202-211.
16. Hancock R.E., “The bacterial outer membrane as a drug barrier”. Trends Microbiol., 1997; 5; 37-42.
17. Harrison-Balestra C., Cazzaniga A.L., Davis S.C., Mertz P.M., “A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy”. Dermatol. Surg., 2003; 29; 631–635.
18. Hetrick E.M., Shin J.H., Paul H.S., Schoenfisch M.H., “Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles”. Biomaterials, 2009; 30; 2782-2789.
19. Jamal M., Hussain T., Das C.R., Andleeb S., “Characterization of Siphoviridae phage Z and studying its efficacy against multi-drug resistant (MDR) Klebsiella pneumoniae planktonic cells and biofilm”. J Med Microbiol., 2015; 64; 454-462. DOI: 10.1099/jmm.0.000040
20. Ji G., Beavis R.C., Novick R.P., “Cell density control of staphylococcal virulence mediated by an octapeptide pheromone”. Proc Natl Acad Sci., 1995; 92; 12055-12059.
21. Khan S., Singh P., Ansari M., Asthana A., “Isolation of Shigella species and their resistance patterns to a panel of fifteen antibiotics in mid and far western region of Nepal”. Asian Pacific J Tropical Dis., 2014; 4; 30-34.
22. Kraigsley A., Ronney P., Finkel S., “Hydrodynamic influences on biofilm formation and growth”. Retrieved Aug 22, 2017.
23. Lewis K., “Multidrug tolerance of biofilms and persister cells”. Bacterial biofilms. Springer. Antimicrobial Agents Chemother., 2008; 51; 1934-1938.
24. Lewis K., “Riddle of biofilm resistance”. Antimicrobial agents and chemotherapy, 2001; 45(4); 999-1007.
25. Ma L., Conover M., Lu H., Parsek M.R., Bayles K., Wozniak D.J., “Assembly and development of the Pseudomonas aeruginosa biofilm matrix”. PLoS Pathogens, 2009; 5; e1000354. DOI: https://doi.org/10.1371/journal.ppat.1000354
26. Mah T.F., O’toole G.A., “Mechanisms of biofilm resistance to antimicrobial agents”. Trends Microbiol., 2001; 9; 34-39.
27. Malic S., Hill K.E., Playle R., Thomas D.W., Williams D.W., “In vitro interactions of chronic wound bacteria in biofilms”. J. Wound Care., 2011; 20; 569–577.
28. Mckenney D., Hubner J., Muller E., Wang Y., Goldmann D.A., Pier G.B., “The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesion”. Infect Immunity, 1998; 66; 4711-4720.
29. Miller M.B., Bassler B.L., “Quorum sensing in bacteria”. Annu Rev Microbiol., 2001; 55; 165-199.
30. Naves P., del Prado G., Huelves L., Rodríguez-Cerrato V., Ruiz V., Ponte M.C., Soriano F., “Effects of human serum albumin, ibuprofen and N-acetyl-l-cysteine against biofilm formation by pathogenic Escherichia coli strains”. J Hospital Infect., 2010; 76; 165-170.
31. Neut D.C., van der Mei H.C., Bulstra S.K., Busscher H.J., “The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics”. Acta Orthopaedic, 2007; 78; 299-308. DOI: 10.1080/17453670710013843
32. Okada M., Sato I., Cho S.J., Iwata H., Nishio T., Dubnau D., Sakagami Y., “Structure of the Bacillus subtilis quorum-sensing peptide pheromone ComX”. Nat Chem Biol., 2005; 1; 23-24. Doi: 10.1038/nchembio709
33. Parsek M.R., Singh P.K., “Bacterial biofilms: an emerging link to disease pathogenesis”. Annu Rev Microbiol., 2003; 57; 677-701.
34. Percival S.L. et al. (eds.), “Biofilms and Veterinary Medicine”. Springer Series on Biofilms 6, DOI 10.1007/978-3-642-21289-5_2,Springer-Verlag Berlin Heidelberg 2011.
35. Percival S.L., Hill K.E., Malic S., Thomas D.W., Williams D.W., “Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms”. Wound Repair Regen., 2011; 19; 1–9.
36. Rajan S., Saiman L., “Pulmonary infections in patients with cystic fibrosis”. Semin Respir Infect., 2002; 17; 47-56.
37. Rai M.K., Deshmukh S.D., Ingle A.P., Gade A.K., “Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria”. J Appl Microbiol., 2012; 112; 841-852.
38. Rasko D.A., Sperandio V., “Anti-virulence strategies to combat bacteria-mediated disease”. Nature Rev. Drug Discov., 2010; 9; 117–128.
39. Romero D., Kolter R., “Will biofilm disassembly agents make it to market?” Trends Microbiol., 2011; 19; 304–306.
40. Sekhar S., Kumar R., Chakraborti A., “Role of biofilm formation in the persistent colonization of Haemophilus influenzae in children from northern India”. J Med Microbiol., 2009; 58; 1428-1432.
41. Singh P.K., Schaefer A.L., Parsek M.R., Moninger T.O., Welsh M.J., Greenberg E.P., “Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms”. Nature, 2000; 407(6805); 762-764.
42. Sreenivasan P. et al., “Clinical response to antibiotics among children with bloody diarrhea”. Indian Paediatrics, 2013; 50; 340-341.
43. Sritharan M., Sritharan V., “Emerging problems in the management of infectious diseases: the Biofilms”. Indian J Med Microbiol., 2004; 22(3); 140-142.
44. Stewart P.S., Franklin M.J., “Physiological heterogeneity in biofilms”. Nat Rev Microbiol., 2008; 6; 199-210.
45. Thurlow L.R., Hanke M.L., Fritz T., Angle A., Aldrich A., Williams S.H., Engebretsen I.L., Bayles K.W., Horswill A.R., Kielian T., “Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo”. J. Immunol., 2011; 186; 6585–6596.
46. Ward K.H., Olson M.E., Lam K., Costerton J.W., “Mechanism of persistent infection associated with peritoneal implant”. J Med Microbiol., 1992; 36; 406.
47. Wolcott R.D., Rhoads D.D., Bennett M.E., Wolcott B.M., Gogokhia L., Costerton J.W., Dowd S.E., “Chronic wounds and the medical biofilm paradigm”. J. Wound Care., 2010; 19; 45–53.
48. Wolcott R.D., Rumbaugh K.P., James G., Schultz G., Phillips P., Yang Q., Watters C., Steward P.S., Dowd S.E., “Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window”. J. Wound Care., 2010; 19; 320–328.
49. Xiu Z., Zhang Q., Puppala H.L., Colvin V.L., Alvarez P.J.J., “Negligible particle-specific antibacterial activity of silver nanoparticles”. Nano lett., 2012; 12(8); 4271–4275. DOI:10.1021/nl301934w

Search

Microbial Biofilms: Pathogenicity and Treatment strategies

RECOMMENDED POSTS

Subscribe with us

Jobs by Category